# Bictegravir in the Elderly Living With HIV (BICEP)

> **NCT05064020** · — · ACTIVE_NOT_RECRUITING · sponsor: **State University of New York at Buffalo** · enrollment: 162 (estimated)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]

## Key facts

- **NCT ID:** NCT05064020
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-08-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2024-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05064020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05064020, "Bictegravir in the Elderly Living With HIV (BICEP)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05064020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*